clobazam has been researched along with cannabidiol in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.44) | 29.6817 |
| 2010's | 8 (19.51) | 24.3611 |
| 2020's | 32 (78.05) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bruno, PL; Geffrey, AL; Pollack, SF; Thiele, EA | 1 |
| Bebin, EM; Cutter, GR; Gaston, TE; Liu, Y; Szaflarski, JP | 1 |
| Carson, RP; Carter, EG; Doll, ED; Fu, C; Porcari, GS | 1 |
| Appleton, R; Devinsky, O; Greenwood, S; Harden, CL; Morrison, G; Patel, AD; Sommerville, K; Thiele, EA; Wong, MH | 1 |
| Blakey, G; Crockett, J; Morrison, G; Sommerville, K | 1 |
| Ampah, SB; Bebin, EM; Cutter, GR; Gaston, TE; Grayson, LP; Liu, Y; Szaflarski, JP | 1 |
| Abelev, SV; Absalom, NL; Anderson, LL; Arnold, JC; Chebib, M; Doohan, PT; Low, IK; Martin, LJ; McGregor, IS | 1 |
| Bergmann, KR; Broekhuizen, K; Groeneveld, GJ | 1 |
| Anagnos, CJ; Bruno, PL; Savage, TE; Skirvin, LA; Sourbron, J; Thiele, EA; Wolper, ES | 1 |
| Mandelbaum, DE | 2 |
| Brigo, F; Del Giovane, C; Lattanzi, S; Nardone, R; Silvestrini, M; Striano, P; Trinka, E; Zaccara, G | 1 |
| Bialer, M; Perucca, E | 2 |
| Checketts, D; Devinsky, O; Dunayevich, E; Knappertz, V; Morrison, G; Thiele, EA; Wright, S | 1 |
| Crockett, J; Morrison, G; Taylor, L; VanLandingham, KE | 1 |
| Brigo, F; Lattanzi, S; Trinka, E | 1 |
| Cáceres-Guido, P; Maldonado, C; Riva, N; Schaiquevich, P; Vázquez, M | 1 |
| Critchley, D; Gidal, B; Morrison, G; Patsalos, PN; Szaflarski, JP; VanLandingham, K | 1 |
| Bhathal, H; Checketts, D; Chin, RFM; Dunayevich, E; Gunning, B; Mazurkiewicz-Bełdzińska, M; Nortvedt, C | 1 |
| Czuczwar, SJ | 1 |
| Dowd, Z; Gilmartin, CGS; Harijan, P; Parker, APJ | 1 |
| Brigo, F; Eltze, C; Jones, K; Matricardi, S | 1 |
| Carreño-Martínez, M; Gil Nagel-Rein, A; López-González, FJ; Villanueva, V | 1 |
| Bruno, PL; Fleming, B; Grinspoon, R; Patel, S; Skirvin, LA; Thiele, EA; Wade, C; Wolper, E | 1 |
| Balestrini, S; Hudgell, K; Nashef, L; Ritter, LM; Sidhu, MK; Silvennoinen, K; Sisodiya, SM | 1 |
| García-Peñas, JJ; Gil Nagel-Rein, A; Sánchez-Carpintero, R; Villanueva-Haba, V | 1 |
| Główka, AK; Główka, FK; Karaźniewicz-Łada, M; Mikulska, AA | 1 |
| Schubert-Bast, S; Strzelczyk, A | 2 |
| Ameen, R; Bansal, D; Devi, N; Madaan, P; Sahu, JK | 1 |
| Samanta, D | 1 |
| Bonaventura, CD; Capovilla, G; Coppola, A; Elia, M; Ferlazzo, E; Gobbi, G; Marini, C; Meletti, S; Riva, A; Romeo, A; Santoro, K; Striano, P; Verrotti, A | 1 |
| Battino, D; Bromley, R; Kochen, S; Meador, KJ; Pennell, PB; Thomas, SV; Tomson, T | 1 |
| Aparasu, R; Estes, E; Reddy, DS; Talwar, A | 1 |
| Bast, T; Becker, LL; Bertsche, A; Borggraefe, I; Boßelmann, CM; De Vries, H; Fahrbach, J; Hertzberg, C; Herz, NA; Hirsch, M; Holtkamp, M; Janello, C; Kaindl, AM; Klotz, KA; Kluger, GJ; Kühne, F; Kurlemann, G; Lerche, H; Makridis, KL; Prager, C; Pringsheim, M; Schubert-Bast, S; Schulz, J; Schulze-Bonhage, A; Steinbart, D; Steinhoff, BJ; Strzelczyk, A; Syrbe, S; von Podewils, F; Wagner, C; Wagner, J; Wilken, B | 1 |
| Felton, E; Georgieva, D; Gidal, BE; Hartkopf, K; Hawk, L; Hsu, D; Langley, J; Margolis, A; Struck, A | 1 |
| Arzimanoglou, A; Auvin, S; Berquin, P; Cross, JH; Desurkar, A; Fuller, D; Nabbout, R; Nortvedt, C; Pulitano, P; Rosati, A; Soto, V; Villanueva, V | 1 |
| Bebin, EM; Cutter, GR; Gaston, TE; Grayson, L; Szaflarski, JP | 1 |
15 review(s) available for clobazam and cannabidiol
| Article | Year |
|---|---|
Cannabidiol efficacy and clobazam status: A systematic review and meta-analysis.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Randomized Controlled Trials as Topic; Seizures; Treatment Outcome | 2020 |
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Evidence-Based Medicine; Humans; Lennox Gastaut Syndrome; Randomized Controlled Trials as Topic; Seizures | 2020 |
Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Randomized Controlled Trials as Topic; Seizures | 2020 |
Clinical pharmacology of cannabidiol in refractory epilepsy.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Drug Resistant Epilepsy; Humans; Quality of Life | 2020 |
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
Topics: Anticonvulsants; Cannabidiol; Clinical Trials as Topic; Clobazam; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Dioxolanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Fatty Acids, Monounsaturated; Humans; Lennox Gastaut Syndrome; Valproic Acid | 2020 |
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.
Topics: Adult; Anticonvulsants; Cannabidiol; Clobazam; Epilepsies, Myoclonic; Female; Humans; Lennox Gastaut Syndrome; Male; Randomized Controlled Trials as Topic | 2021 |
Interaction of cannabidiol with other antiseizure medications: A narrative review.
Topics: Animals; Anticonvulsants; Cannabidiol; Clobazam; Drug Interactions; Humans; Lennox Gastaut Syndrome; Randomized Controlled Trials as Topic | 2021 |
Anti-seizure medications for Lennox-Gastaut syndrome.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Cannabidiol; Child; Child, Preschool; Cinnamates; Clobazam; Electroencephalography; Felbamate; Humans; Lamotrigine; Lennox Gastaut Syndrome; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Topiramate; Triazoles; Wakefulness; Young Adult | 2021 |
New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
Topics: Administration, Oral; Adolescent; Algorithms; Anticonvulsants; Cannabidiol; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Clobazam; Compassionate Use Trials; Double-Blind Method; Drug Resistant Epilepsy; Drug Synergism; Epilepsies, Myoclonic; Humans; Infant; Lennox Gastaut Syndrome; Treatment Outcome | 2021 |
Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Clonazepam; Diazepam; Dioxolanes; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Phenobarbital; Practice Guidelines as Topic; Pyrrolidinones; Spain; Triazoles; Valproic Acid | 2021 |
Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients.
Topics: Anticonvulsants; Cannabidiol; Carbamazepine; Clobazam; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Epilepsy; Humans; Nutrients; SARS-CoV-2 | 2021 |
Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Humans; Lennox Gastaut Syndrome; Network Meta-Analysis; Randomized Controlled Trials as Topic; Seizures; Treatment Outcome | 2022 |
Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force
Topics: Breast Feeding; Cannabidiol; Carbamazepine; Child; Clobazam; Clonazepam; Epilepsy; Ethosuximide; Everolimus; Felbamate; Female; Fenfluramine; Gabapentin; Humans; Infant; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Prospective Studies; Tiagabine; Topiramate; Valproic Acid; Vigabatrin; Zonisamide | 2022 |
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Topics: Autism Spectrum Disorder; Bromides; Cannabidiol; Clobazam; Cognition; Ethosuximide; Everolimus; Felbamate; Fenfluramine; Humans; Lacosamide; Lamotrigine; Levetiracetam; Pregabalin; Spasms, Infantile; Sulfides; Topiramate; Valproic Acid; Vigabatrin; Zinc Compounds; Zonisamide | 2022 |
Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis.
Topics: Adult; Anticonvulsants; Cannabidiol; Child; Clobazam; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Epilepsy; Humans; Lennox Gastaut Syndrome; Seizures; Treatment Outcome | 2023 |
5 trial(s) available for clobazam and cannabidiol
| Article | Year |
|---|---|
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
Topics: Anticonvulsants; Benzodiazepines; Cannabidiol; Child; Child, Preschool; Clobazam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Myoclonic; Follow-Up Studies; Humans; Treatment Outcome | 2018 |
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects.
Topics: Adult; Anticonvulsants; Cannabidiol; Clobazam; Cytochrome P-450 CYP2C19; Dioxolanes; Drug Interactions; Female; Genotype; Healthy Volunteers; Humans; Male; Valproic Acid | 2019 |
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program.
Topics: Adolescent; Adult; Anticonvulsants; Cannabidiol; Child; Clobazam; Drug Interactions; Drug Resistant Epilepsy; Female; Humans; Male; Treatment Outcome; Young Adult | 2019 |
A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam.
Topics: Adult; Anticonvulsants; Cannabidiol; Clobazam; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged | 2020 |
Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Cannabidiol; Child; Child, Preschool; Clobazam; Drug Resistant Epilepsy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lennox Gastaut Syndrome; Male; Middle Aged; Seizures; Young Adult | 2023 |
21 other study(ies) available for clobazam and cannabidiol
| Article | Year |
|---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.
Topics: Adolescent; Benzodiazepines; Cannabidiol; Child; Child, Preschool; Clobazam; Cytochrome P-450 Enzyme System; Drug Interactions; Epilepsy; Female; Humans; Male; Young Adult | 2015 |
Interactions between cannabidiol and commonly used antiepileptic drugs.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Benzodiazepines; Cannabidiol; Child; Child, Preschool; Clobazam; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Female; Fructose; Humans; Male; Middle Aged; Topiramate; Triazoles; Young Adult | 2017 |
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
Topics: Adolescent; Anticonvulsants; Attention; Cannabidiol; Cannabis; Child; Child, Preschool; Clobazam; Drug Resistant Epilepsy; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Hospitals; Humans; Longitudinal Studies; Male; Retrospective Studies; Seizures; Treatment Outcome; United States; United States Food and Drug Administration | 2018 |
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
Topics: Animals; Anticonvulsants; Cannabidiol; Clobazam; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Mice; Mice, Transgenic; NAV1.1 Voltage-Gated Sodium Channel | 2019 |
Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop-seizure frequency.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Humans; Lennox Gastaut Syndrome; Seizures | 2020 |
Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
Topics: Adolescent; Adult; Anticonvulsants; Cannabidiol; Child; Child, Preschool; Clobazam; Drug Resistant Epilepsy; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Seizures; Treatment Outcome; Young Adult | 2020 |
Re: Efficacy of Cannabidiol in Subjects with Refractory Epilepsy Relative to Concomitant Use of Clobazam.
Topics: Anticonvulsants; Benzodiazepines; Cannabidiol; Clobazam; Drug Resistant Epilepsy; Humans; Seizures | 2022 |
Response: Cannabidiol antiseizure activity and its interactions with clobazam: "It's déjà vu all over again" Yogi Berra.
Topics: Cannabidiol; Clobazam; Randomized Controlled Trials as Topic | 2020 |
Cannabidiol antiseizure activity and its interactions with clobazam: "It's déjà vu all over again" Yogi Berra.
Topics: Cannabidiol; Clobazam; Randomized Controlled Trials as Topic | 2020 |
Cannabidiol efficacy and clobazam coadministration: Where do we stand now?
Topics: Anticonvulsants; Cannabidiol; Clobazam; Drug Resistant Epilepsy; Humans | 2020 |
Commentary on: Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Humans; Lennox Gastaut Syndrome | 2020 |
The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
Topics: Adolescent; Anticonvulsants; Cannabidiol; Child; Child, Preschool; Clobazam; Dose-Response Relationship, Drug; Drug Resistant Epilepsy; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Retrospective Studies; Seizures; Treatment Outcome; Tuberous Sclerosis; Young Adult | 2021 |
Two-center experience of cannabidiol use in adults with Dravet syndrome.
Topics: Adult; Anticonvulsants; Cannabidiol; Clobazam; Epilepsies, Myoclonic; Female; Humans; Middle Aged; Quality of Life; Young Adult | 2021 |
A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.
Topics: Adult; Anticonvulsants; Cannabidiol; Child; Clobazam; Drug Therapy, Combination; Epilepsies, Myoclonic; Epileptic Syndromes; Fenfluramine; Humans; Sleepiness; Spasms, Infantile; Topiramate | 2022 |
Pharmacotherapeutic management of seizures in patients with Angleman Syndrome.
Topics: Anticonvulsants; Cannabidiol; Child; Clobazam; Clonazepam; Ethosuximide; Humans; Lamotrigine; Levetiracetam; Quality of Life; Seizures; Topiramate; Valproic Acid | 2022 |
An Italian consensus on the management of Lennox-Gastaut syndrome.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Consensus; Fenfluramine; Humans; Lamotrigine; Lennox Gastaut Syndrome; Quality of Life; Topiramate; Valproic Acid | 2022 |
Real-world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Cannabidiol; Child; Clobazam; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Middle Aged; Retrospective Studies; Seizures; Young Adult | 2023 |
Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome.
Topics: Adolescent; Anticonvulsants; Cannabidiol; Clobazam; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Retrospective Studies; Seizures; Treatment Outcome | 2023 |
Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program.
Topics: Adult; Anticonvulsants; Cannabidiol; Child; Clobazam; Drug Interactions; Humans; Topiramate | 2023 |